🇺🇸 Rezolsta in United States
241 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 241
Most-reported reactions
- Drug Interaction — 63 reports (26.14%)
- Off Label Use — 27 reports (11.2%)
- Covid-19 — 24 reports (9.96%)
- Death — 24 reports (9.96%)
- Diarrhoea — 20 reports (8.3%)
- Product Use In Unapproved Indication — 19 reports (7.88%)
- Vomiting — 18 reports (7.47%)
- Lower Respiratory Tract Infection — 16 reports (6.64%)
- Atrial Fibrillation — 15 reports (6.22%)
- Blood Creatine Phosphokinase Increased — 15 reports (6.22%)
Rezolsta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Rezolsta approved in United States?
Rezolsta does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Rezolsta in United States?
St Stephens Aids Trust is the originator. The local marketing authorisation holder may differ — check the official source linked above.